LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
for Ulcerative Colitis (UC)
50 locations incl. Phoenix
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 80
Code: NCT07415044·Phase 2·Recruiting·Listed Feb 2026
GI Alliance - Garland
Clinical research site in Garland, Texas · Digestive Health Associates of Texas: Garland - N PGB Hwy, TX, 7150 N President George Bush Hwy Suite 201 & Suite 202, Garland, TX 75044 · (972) 771-2222 · Website
Part of GI Alliance
As of July 2026, 4 paid clinical trials are recruiting at GI Alliance - Garland in Garland, Texas. Active studies at this site cover conditions such as Celiac Disease, Moderately to Severely Active Crohn Disease and Ulcerative Colitis. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at GI Alliance - Garland (4)
Study of DONQ52 in Active Celiac Disease
for Celiac Disease
55 locations incl. Anniston
Sponsor: Chugai Pharmaceutical
Sex: All·Age: 18 - 75
Code: NCT07239336·Phase 2·Recruiting·Listed Nov 2025
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
for Ulcerative Colitis
40 locations incl. Scottsdale
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 80
Code: NCT07186101·Phase 2·Recruiting·Listed Sep 2025
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
for Moderately to Severely Active Crohn Disease
43 locations incl. Fairhope
Sponsor: Abivax S.A.
Sex: All·Age: 18 - 75
Code: NCT06456593·Phase 2·Recruiting·Listed Jun 2024
More research sites in Garland
- GI Alliance (2 trials)
- 89bio Clinical Study Site (1 trial)
- DHAT Reseach Institute (1 trial)
- Dallas Cancer Specialists (1 trial)
- Epic Medical Research - Garland (1 trial)
- Epic Medical Research- Garland (1 trial)
- GI Alliance - Digestive Health Associates of Texas - DHAT (1 trial)
- Local Institution - 0046 (1 trial)
- Mirador Therapeutics Selected Site (1 trial)
- Renal Disease Research Institute (1 trial)